| |
| |
|
| Insider
Information: |
Lebel Francois |
| Relationship: |
Chief Medical Officer |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
845,356 |
|
|
Indirect Shares
|
7,226 |
|
|
| Direct
Value |
$697,949 |
|
|
|
Indirect Value
|
$7,443 |
|
|
| Total
Shares |
852,582 |
|
|
| Total
Value |
$705,392 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alaunos Therapeutics |
TCRT |
Executive Vice Preside... |
2017-12-31 |
200,566 |
2015-06-09 |
0 |
Premium* |
|
|
Spectrum Pharmaceuticals Inc |
SPPI |
Chief Medical Officer |
2022-06-23 |
644,790 |
2022-06-23 |
7,226 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2015-06-09 |
4 |
S |
$10.12 |
$506,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2015-06-09 |
4 |
S |
$10.12 |
$506,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical OfficerOfficer |
• – – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
948 |
|
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2015-06-09 |
4 |
OE |
$4.34 |
$217,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2015-06-09 |
4 |
OE |
$4.34 |
$217,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical OfficerOfficer |
• – – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,250 |
|
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-11-06 |
4 |
AS |
$8.16 |
$56,825 |
D/D |
(6,963) |
113,970 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
120,250 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2016-12-31 |
4 |
D |
$5.35 |
$115,918 |
D/D |
(21,667) |
137,683 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2016-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
94,350 |
159,350 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2017-12-31 |
4 |
D |
$4.14 |
$89,701 |
D/D |
(21,667) |
200,566 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2017-12-30 |
4 |
D |
$4.14 |
$130,203 |
D/D |
(31,450) |
222,233 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-04-05 |
4 |
AS |
$1.41 |
$1,927 |
D/D |
(1,367) |
252,513 |
0 |
% |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President R&D |
• – – |
2017-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
116,000 |
253,683 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-04-04 |
4 |
AS |
$1.35 |
$1,627 |
D/D |
(1,205) |
253,880 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-03-16 |
4 |
AS |
$0.71 |
$17,724 |
D/D |
(25,105) |
255,085 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-03-15 |
4 |
AS |
$0.71 |
$17,717 |
D/D |
(25,130) |
280,190 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-23 |
4 |
AS |
$3.35 |
$13,959 |
D/D |
(4,167) |
292,729 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-22 |
4 |
AS |
$3.16 |
$17,320 |
D/D |
(5,474) |
296,896 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-11-06 |
4 |
AS |
$3.50 |
$24,609 |
D/D |
(7,025) |
301,424 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-04-03 |
4 |
AS |
$2.18 |
$1,862 |
D/D |
(854) |
302,370 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-04-02 |
4 |
AS |
$2.17 |
$2,667 |
D/D |
(1,228) |
303,224 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
188,285 |
304,452 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-02-24 |
4 |
AS |
$0.64 |
$9,413 |
D/D |
(14,708) |
305,320 |
0 |
% |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
